Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Biorem's annualized return on capital (ROC %) for the quarter that ended in Jun. 2026 was 45.33%.
As of today (2026-08-18), Biorem's WACC % is 8.07%. Biorem's ROC % is 41.48% (calculated using TTM income statement data).
Biorem generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Biorem's WACC % is 8.07%. Biorem's ROC % is 41.48% (calculated using TTM income statement data).
Biorem generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
Be Aware
Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Biorem ROC % Related Terms
Biorem ROC % Historical Data
* Premium members only.
The historical data trend for Biorem's ROC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Operating Income data used here is four times the quarterly (Jun. 2026) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biorem (BIRMF) has a ROC % of 45.33% as of Jun. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Biorem and its competitors.
Is Biorem's ROC % too high?
Biorem's current ROC % is 45.33%. The Industrial Products industry median ROC % is 5.26. Biorem's value of 45.33% is 761.8% above this industry median. Overall, Biorem has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biorem's ROC % compare to VLTO and ZWS?
Biorem's ROC % of 45.33% can be compared against companies in the Industrial Products industry. The industry median ROC % is 5.26. Biorem's value of 45.33% is 761.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for an Industrial Products company?
The median ROC % among Industrial Products companies is 5.26, based on 3,031 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biorem's current ROC % of 45.33% is 761.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Biorem and its competitors. For the Industrial Products industry, the median ROC % is 5.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biorem's current ROC % is 45.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.32, compared to a current price of $2.65 — trading 14.2% above its estimated fair value. The current ROC % is 45.33% and 761.8% above the Industrial Products industry median of 5.26. Biorem's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Biorem (BIRMF), the current ROC % is 45.33% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biorem (BIRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Biorem stock appears to be overvalued.
The current stock price of $2.65 is trading 14.2% above its estimated GF Value™ of $2.32.
GuruFocus considers Biorem to be Modestly Overvalued.
Key valuation signals for BIRMF:
ROC %: 45.33%
GF Value™: $2.32 vs. price of $2.65 (14.2% above fair value)
Industry Position: 761.8% above the Industrial Products median
No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
86GF Score
Get the complete analysis for BIRMF
ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIRMF has been successfully added to your 
